Bài viết tiến hành nghiên cứu chi phí trực tiếp điều trị đợt cấp bệnh phổi tắc nghẽn mạn tính (COPD) được thực hiện tại khoa hô hấp bệnh viện E từ tháng 10/2019 đến tháng 3/2020. | Phân tích chi phí điều trị trực tiếp đợt cấp bệnh phổi tắc nghẽn mạn tính tại Khoa Hô Hấp Bệnh viện E từ tháng 10 năm 2019 đến tháng 3 năm 2020 VNU Journal of Science Medical and Pharmaceutical Sciences Vol. 36 No. 2 2020 85-93 Original Article Analysis of Direct Treatment Cost for Exacerbation of Chronic Obstructive Pulmonary Disease in E Hospital from October 2019 to March 2020 Bui Thi Xuan Ngo Tien Thanh To Khanh Linh 3 VNU School of Medicine and Pharmacy Vietnam National University Hanoi 144 Xuan Thuy Cau Giay Hanoi Vietnam Received 13 May 2020 Revised 28 May 2020 Accepted 20 June 2020 Abstracts This study analyzes the direct treatment cost for exacerbation of chronic obstructive pulmonary disease COPD at the Department of Pulmonology E Hospital from October 2019 to March 2020. The study results show that the average direct treatment cost for exacerbation of COPD was VND 9 102 the highest cost was VND 36 304 614 and the lowest cost VND 2 309 961. Among the direct treatment cost components drug cost showed the highest proportion followed by hospital bed then surgical procedures tests diagnostic imaging functional exploration examination and medical supplies. The cost of antibiotics accounted for of the drug cost. The average number of hospitalization days was closely relating to the direct cost. Besides age and comorbidity also affected the number of hospitalization days. The average health insurance support for each patient was up to of the total treatment cost. The results also show that the cost of treatment in Vietnam is lower than some countries in the region and the proportions of the cost components presented in different studies in Vietnam are different. Keywords Direct cost exacerbation of COPD E hospital. Corresponding author. E-mail address sealotus82@ https 2588-1132 85 86 . Xuan et al. VNU Journal of Science Medical and Pharmaceutical Sciences Vol. 36 No. 2 2020 84-93 Phân
